87 FR 236 pgs. 75669-75670 - Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially Exclusive Patent License
Type: NOTICEVolume: 87Number: 236Pages: 75669 - 75670
Pages: 75669, 75670Docket number: [Notice (22-099)]
FR document: [FR Doc. 2022-26825 Filed 12-8-22; 8:45 am]
Agency: National Aeronautics and Space Administration
Official PDF Version: PDF Version
[top]
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice (22-099)]
Notice of Intent To Grant an Exclusive, Co-Exclusive or Partially Exclusive Patent License
AGENCY:
National Aeronautics and Space Administration.
ACTION:
Notice of intent to grant exclusive, co-exclusive or partially exclusive patent license.
SUMMARY:
NASA hereby gives notice of its intent to grant an exclusive, co-exclusive or partially exclusive patent license to practice the inventions described and claimed in the patents and/or patent applications listed in SUPPLEMENTARY INFORMATION below.
DATES:
[top] The prospective exclusive, co-exclusive or partially exclusive license
ADDRESSES:
Written objections relating to the prospective license or requests for further information may be submitted to Agency Counsel for Intellectual Property, NASA Headquarters at email: hq-patentoffice@mail.nasa.gov. Questions may be directed to Phone: (202) 358-3437.
SUPPLEMENTARY INFORMATION:
NASA intends to grant an exclusive, co-exclusive, or partially exclusive patent license in the United States to practice its undivided interest in the jointly-owned inventions described and claimed in: U.S. Patent 11,406,867 B1, "Portable System and Apparatus for Dynamometry, Exercise, and Rehabilitation" to Biodex Medical Systems, a Mirion Medical Company, having its principal place of business in Shirley, New York. The fields of use may be limited. NASA has not yet made a final determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period.
This notice of intent to grant an exclusive, co-exclusive or partially exclusive patent license is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective license will comply with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Information about other NASA inventions available for licensing can be found online at https://technology.nasa.gov.
Helen M. Galus,
Agency Counsel for Intellectual Property.
[FR Doc. 2022-26825 Filed 12-8-22; 8:45 am]
BILLING CODE 7510-13-P